Home › Clinical Tools › D'Amico

🧬 D'Amico Prostate Cancer Risk Group

UseWhen to use: localized prostate cancer counseling with PSA, Gleason, and T stage.

Loading calculator…

StrataLow / intermediate / high historical groups; refine with NCCN and imaging.

LimitsWhen not to use: metastatic disease staging alone. · Pitfall: ignoring favorable vs unfavorable intermediate. · Not a sole treatment order.

SourceD'Amico risk classification for prostate cancer (1998)

Runs locally in your browser (no PHI uploaded). For licensed clinicians — not a substitute for clinical judgement.
Stored on this device for revisit reminders

This-shift next steps

After scoring: open the scene pack, peer scores, and the matching pathway. Local reference — no HIS write.

Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.

Methodology · worked example, guidelines & full notes
Clinical takeaway

Three groups.

When to use

When to use: localized prostate cancer counseling with PSA, Gleason, and T stage.

How it works

Low: PSA ≤10 + Gleason ≤6 + T1–T2a; Int: PSA 10–20 or G7 or T2b; High: PSA >20 or G8–10 or ≥T2c.

Key points

  • Three groups.
  • PSA + grade + T.
  • Next: modern risk tools / shared decision.

References

  • D'Amico risk classification for prostate cancer (1998)

Worked calculation

The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.

PSA (ng/mL)8.5 ng/mL
Gleason sum (or Grade Group equivalent)7 (Grade Group 2–3)
Clinical T stageT2b

→D'AmicoIntermediate

  • Inputs:PSA 8.5, Gleason 7, T T2b
  • Cue:Intermediate — refine with Grade Group / NCCN favorable vs unfavorable
PSA (ng/mL)8.5 ng/mL
Gleason sum (or Grade Group equivalent)≤6 (Grade Group 1)
Clinical T stageT1–T2a

→D'AmicoLow

  • Inputs:PSA 8.5, Gleason 6, T T1–T2a
  • Cue:Low — active surveillance often discussed
Verification & sources · governance
FAQ

Frequently asked questions

Does D'Amico Prostate Cancer Risk Group upload patient data? Where is it calculated?
Calculation runs locally in the browser; inputs and results are not uploaded. For licensed clinicians only; interpret with history, investigations and local protocols — not a diagnosis or prescription.
How is D'Amico Prostate Cancer Risk Group calculated in practice? Can you show a worked example?
Inputs: PSA (ng/mL) 8.5 ng/mL, Gleason sum (or Grade Group equivalent) 7 (Grade Group 2–3), Clinical T stage T2b → Result: D'Amico Intermediate(Inputs: PSA 8.5, Gleason 7, T T2b, Cue: Intermediate — refine with Grade Group / NCCN favorable vs unfavorable) Inputs: PSA (ng/mL) 8.5 ng/mL, Gleason sum (or Grade Group equivalent) ≤6 (Grade Group 1), Clinical T stage T1–T2a → Result: D'Amico Low(Inputs: PSA 8.5, Gleason 6, T T1–T2a, Cue: Low — active surveillance often discussed)
Related tools